Author’s Name(s): Kristina Nazzicone, Rachel Kim, Alexa Fine, Aidan Pucchio, Laura Wheaton, Christine LawAuthor’s Disclosure Block: Kristina Nazzicone, none; Rachel Kim, none; Alexa Fine, none; Aidan Pucchio, none; Laura Wheaton, LW served as an advisor for Alexion Pharma Canada on Koselugo (Selumetinib) in February 2024; Christine Law, none Abstract BodyPurpose: Ocular involvement in pediatric leukemia is often under-r...